Tower Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Tower Wealth Partners's AMGN Position: Q2 2026 in Review
Tower Wealth Partners increased its Amgen (AMGN) stake by 6.3% in Q2 2026, buying an estimated $27K and bringing the position to 1,333 shares worth $483K. The position accounts for 0.24% of the portfolio, ranked #52.
Tower Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 11 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Tower Wealth Partners held 1,333 shares of Amgen worth $483K as of Q2 2026.
- Tower Wealth Partners bought 79 Amgen shares in Q2 2026, an estimated $27K.
- Amgen made up 0.24% of Tower Wealth Partners's portfolio in Q2 2026, its #52 holding.
- Tower Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 11 quarters since.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Tower Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.